Skip to main content

Table 2 Cancer type and stage of patients receiving cisplatin based chemotherapy

From: Incidence of Venous Thromboembolism in cancer patients treated with Cisplatin based chemotherapy — a cohort study

Site of cancer Stage of tumor (N = 200) Total (%)
Early (%) Locally advanced (%) Metastatic (%)
Lung 1 (0.5) 16 (8) 21 (10.5) 38 (19)
Gastric/GEJ 2 (1) 8 (4) 10 (5) 20 (10)
Head and Neck 1 (0.5) 14 (7) 19 (9.5) 34 (17)
Pancreatic 0 4 (2) 9 (4.5) 13 (6.5)
Ovarian 1 (0.5) 5 (2.5) 0 6 (3)
Esophageal 1 (0.5) 6 (3) 9 (4.5) 16 (8)
Germ Cell 3 (1.5) 1 (0.5) 9 (4.5) 13 (6.5)
Cervical/Vulvar 0 3 (1.5) 7 (3.5) 10 (5)
Bladder 0 5 (2.5) 7 (3.5) 12 (6)
Endometrial 1 (0.5) 3 (1.5) 0 4 (2)
Chloangiocarcinoma 0 2 (1) 2 (1) 4 (2)
Breast 0 3 (1.5) 3 (1.5) 6 (3)
Carcinoma of unknown primary (CUP) 0 6 (3) 2 (1) 8 (4)
Gall bladder/peri-ampullary 0 4 (2) 3 (1.5) 7 (3.5)
Lymphomaa 0 9 (4.5) 9 (4.5)
  1. aLymphoma can only be classified into early or advanced stage